文献
J-GLOBAL ID:201802258548655042
整理番号:18A0975394
前内分泌療法中または後に進行したHR+,HER2-乳癌の閉経後患者におけるフルベストラントと併用したドビチニブの第II相無作為化プラセボ対照試験【JST・京大機械翻訳】
Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR + , HER2 - breast cancer that had progressed during or after prior endocrine therapy
著者 (16件):
Musolino Antonino
(Medical Oncology Unit, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy)
,
Campone Mario
(Institut de Cancerologie de l’Ouest, Rene Gauducheau, Saint-Herblain, France)
,
Neven Patrick
(Hospital Gasthuisberg, Leuven, Belgium)
,
Denduluri Neelima
(Virginia Cancer Specialists, US Oncology Research, Arlington, USA)
,
Barrios Carlos H.
(Pontificia Universidade Catolica do Rio Grande do Sul School of Medicine, Porto Alegre, Brazil)
,
Cortes Javier
(Vall d’Hebron Institute of Oncology, Barcelona, Spain)
,
Cortes Javier
(Ramon y Cajal University Hospital, Madrid, Spain)
,
Blackwell Kimberly
(Duke University Medical Center, Durham, USA)
,
Soliman Hatem
(Moffitt Cancer Center, Tampa, USA)
,
Kahan Zsuzsanna
(University of Szeged, Szeged, Hungary)
,
Bonnefoi Herve
(Institut Bergonie Comprehensive Cancer Centre, Universite de Bordeaux, Bordeaux, France)
,
Squires Matthew
(Novartis Pharma AG, Basel, Switzerland)
,
Zhang Yong
(Novartis Pharmaceuticals Corporation, East Hanover, USA)
,
Deudon Stephanie
(Novartis Pharma AG, Basel, Switzerland)
,
Shi Michael M.
(Novartis Pharmaceuticals Corporation, East Hanover, USA)
,
Andre Fabrice
(Institut Gustave Roussy, Villejuif, France)
資料名:
Breast Cancer Research (Web)
(Breast Cancer Research (Web))
巻:
19
号:
1
ページ:
18
発行年:
2017年
JST資料番号:
U7313A
ISSN:
1465-542X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)